Eye Disease Treatment Firm OccuLogix Inc. Files To Go Public

Canada's OccuLogix Inc., whose products treat eye diseases, said on Friday it is planning to raise as much as $100 million in an initial public offering of common stock.
MORE ON THIS TOPIC